Gathering Global Expertise, Shaping the Future of Cancer Care Together

WAIO

Cancer is a global health challenge we face together. Cancer treatment should not stop at national borders.

On July 19, 2025, the 4th ASEAN International Oncology Integrative Medicine Session, jointly hosted by authoritative institutions including the Chinese Anti-Cancer Association (CACA), the Chinese Academy of Integrative Medicine Development Strategy, and the World Academy of Integrative Oncology (WAIO), and co-organized by Sun Yat-sen University Cancer Center, Guangdong Anti-Cancer Association, Hong Kong and Macau Anti-Cancer Association, and Modern Cancer Hospital Guangzhou , will be grandly held in Guangzhou, China.。

This session will bring together leading oncology experts from China, Thailand, Vietnam, Indonesia, the Philippines, Malaysia, and other ASEAN countries. They will engage in in-depth exchanges and sharing on key topics including non-surgical cancer treatments, minimally invasive combination therapies, and the integration of Chinese and Western medicine.

This grand event will serve as a new starting point for promoting cancer prevention and treatment cooperation under the “Belt and Road” initiative, bringing more hope and possibilities to cancer patients in Southeast Asia.

  • Member of China Anti-Cancer Association

    Member of China Anti-Cancer Association

  • World Society for Integrative Oncology(WAIO)

    World Society for Integrative Oncology(WAIO)

  • Sun Yat-sen University Cancer Center

    Sun Yat-sen University Cancer Center

  • Modern Cancer Hospital Guangzhou

    Modern Cancer Hospital Guangzhou

Global Oncology Experts Converge on One Stage, Integrated Medicine Leading the Future of Cancer Care

Jiang Haiping
Jiang Haiping
Professor & Doctoral supervisor | Chief physician
Specialty:He is good at the diagnosis and treatment of gastric cancer, colorectal cancer, external abdominal hernia, anorectal disease, anal preservation operation for low rectal cancer, total mesenteric resection and malnutrition caused by various diseases, and has unique experience in parenteral nutrition, enteral nutrition and nutritional support for critically ill patients.
more
Wang Ying
Wang Ying
Expert of Belt and Road Holistic Integrative Oncology Training Base (Guangdong) of CACA | Associate Professor
Specialty:Prof. Wang has engaged in clinical practices and research of oncology for over 10 years, specialized in immunotherapy, chemotherapy and management of toxic side efforts from treatments , cancer pain treatment, long-term survival guidance and management for patients with gastrointestinal tumors, such as colon-rectal cancer, gastric cancer, liver cancer, and esophageal cancer. She had participated in multiple international and domestic multi-center clinical trials of new anti-tumor drugs.
more
Xia Wen
Xia Wen
Experts of Belt and Road Holistic Integrative Oncology Training Base(Guangdong) of CACA | Associate Chief Physician
Specialty:Dr. Xia is good at individualized breast cancer treatment and whole course management (chemical treatment, endocrine therapy and targeted therapy), breast benign and malignant tumors, breast disease screening, genetic counseling and whole course management.
more
Wang Xiaoxiao
Wang Xiaoxiao
Experts of Belt and Road Holistic Integrative Oncology Training Base(Guangdong) of CACA | Associate Chief Physician
Specialty:Introduction: Associate Chief Physician, Master of Medicine. A committee member of Lymphoma Professional Committee of China Anti-Cancer Association, member of Tumor Clinical Chemotherapy Professional Committee of China Anti-Cancer Association, member of Hematology Oncology Professional Committee of Guangdong Anti-cancer Association, member of Lymphoma Professional Committee of Guangdong Anti-cancer Association, standing member of Hematology Oncology Professional Committee of Guangdong Preventive Medicine Association, deputy director of Young Doctor Branch of Guangzhou Medical Doctor Association, an expert in Internal Medicines of Sun Yat-sen University Cancer Center, an expert in the Belt and Road Holistic Integrative Oncology Training Base (Guangdong) of China Anti-Cancer Association, Medical Experience Dr. Wang excels in Internal Medicines (chemotherapy, targeted therapy) and anti-cancer drug research, especially in malignant lymphoma (non-Hodgkin lymphoma and Hodgkin lymphoma), chem
more
Chen Xiaobing
Chen Xiaobing
Experts of Belt and Road Holistic Integrative Oncology Training Base(Guangdong) of CACA. | Chief physician
Specialty:He specializes in standardized precision treatment of gastric cancer, esophageal cancer, colorectal cancer, liver cancer and other gastrointestinal tumors and lung cancer, breast cancer and etc. He also has rich clinical experience in cancer pain management, rehabilitation of tumor patients, nutrition and psychological treatment, and has in-depth research on "individualized one-stop comprehensive treatment" for elderly tumors.
more
Zhang Fujun
Zhang Fujun
Consultant of St. Stamford Modern Cancer Hospital Guangzhou | Chief Physician
Specialty:Introduction: Oncologist, Chief Physician, Professor, Doctoral Supervisor Expert of Belt and Road Holistic Integrative Oncology Training Base of CACA He works as Chief Physician of Sun Yat-sen University Cancer Center, Deputy Director of Radiological Intervention Research Institute of Sun Yat-sen University, Standing Committee Member and Secretary General of Minimally Invasive Cancer Treatment Specialized Committee of China Anti-Cancer Association, Leader in the Field of Minimally Invasive Cancer Treatment in China, Experts of Belt and Road Holistic Integrative Oncology Training Base of CACA, Consultant of Modern Hospital Guangzhou. Medical Experience: Over the past decade, more than 40 items of new technologies on interventional treatment for tumors have been developed, such as CT-guided I125 particle implantation for tumors, microwave ablation for tumors, radiofrequency ablation for tumors, arterial chemotherapy-catheter implantation,intraesophageal stent implantation, stent implanta
more
Fan Daiming
Fan Daiming
The Council Chairman of China Anti-Cancer Association | the Academician of Chinese Academy of Engineering
Specialty:Prof. Fan Daiming has long been engaged in the basic and clinical research of digestive diseases. Specifically, he has made great contributions to the molecular mechanism, control and prevention of the occurrence and development of gastric cancer.
more
  • Professor He Jianyu
  • Professor Huang Zuoping
  • Professor Song Shijun
  • Professor Dai Wenyan
  • Professor Ma Xiaoying
  • Professor He Jianyu Dialogue with ASEAN Oncology Experts

    ASEAN International Minimally Invasive Oncology Expert
    Minimally Invasive Oncology Expert, Modern Cancer Hospital Guangzhou

    “Without Surgery,securing an extra survival chance.”

    Postdoctoral Fellow from Imperial College London, Ph.D. in Surgery from Shanghai Medical College of Fudan University, Professor He Jianyu has over 30 years of experience in clinical oncology and research, holding concurrent positions in several national oncology academic organizations.
    Specializes in chemotherapy, targeted therapy, immunotherapy, and monoclonal antibody therapy for solid tumors such as liver cancer, breast cancer, lung cancer, gastrointestinal tumors, and nasopharyngeal carcinoma. Particularly experienced in minimally invasive treatments for advanced and metastatic cancers. Proficient in techniques including particle implantation, microwave and radiofrequency ablation, interventional therapy, and solid tumor biopsy. Has established a mature diagnostic and therapeutic system for minimally invasive surgery on neck and bone metastases.

    • 贺建宇教授现场图1
    • 贺建宇教授现场图2
    • 贺建宇教授现场图3
    • Malaysia - Colorectal Cancer - Ms. Zhang

      In July 2024, Ms. Zhang developed abdominal pain and was subsequently diagnosed with sigmoid colon cancer. She underwent resection locally. Shortly after surgery, her condition progressed rapidly, developing diffuse liver metastases, with the largest lesion measuring 46x41 mm. Due to tumor involvement of critical vascular areas, achieving local control was difficult, and conventional treatments faced limitations. In September 2024, she was admitted to Modern Cancer Hospital Guangzhou. After a joint assessment by the MDT specialist team, including Professor He Jianyu, an integrated minimally invasive treatment plan of "cryoablation + interventional embolization" was formulated for her. A re-examination three months later showed significant tumor shrinkage and a marked improvement in her mental state. By February 2025, a follow-up CT scan revealed the tumor had essentially subsided. Her physical strength recovered well, and she resumed daily activities.

      Malaysia - Colorectal Cancer - Ms. Zhang

       

    • Malaysia - Nasopharyngeal Carcinoma - Chong Chee Wei

      In October 2023, Mr. Chong sought medical attention for persistent headaches and was diagnosed with Stage IV nasopharyngeal carcinoma with cervical lymph node metastasis, the largest lesion measuring 7.5 cm in diameter. He underwent several rounds of radiotherapy and chemotherapy locally with poor efficacy, resulting in a drastic weight loss of 30 kg. In April 2024, he traveled to Modern Cancer Hospital Guangzhou for treatment. He received a course of integrated minimally invasive therapy: interventional therapy + targeted therapy + particle implantation. Post-treatment, the tumor shrank by two-thirds, and his physical condition improved significantly. Currently, Mr. Chong's health has markedly improved: the tumor has substantially reduced, his weight is steadily increasing, and his mental state has also recovered well.

      Malaysia - Nasopharyngeal Carcinoma - Chong Chee Wei

      more>

  • Professor Huang Zuoping Professor Huang Zuoping

    Professor Huang Zuoping Dialogue with ASEAN Oncology Experts

    ASEAN International Minimally Invasive Oncology Expert
    Chinese-Western Integrative Expert, Modern Cancer Hospital Guangzhou

    “Targeting tumors, while safeguarding patient’' quality of life.”

    Professor Huang Zuoping has deep expertise in minimally invasive oncology therapy, radiation oncology, and tumor pharmacology. He is dedicated long-term to the precise comprehensive treatment of advanced-stage cancers, combining clinical and research experience.
    Specializes in the diagnosis and treatment of common solid tumors such as nasopharyngeal carcinoma, lung cancer, cervical cancer, breast cancer, colorectal cancer, esophageal cancer, and liver cancer. Proficient in the combined application of minimally invasive interventional therapy, chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Emphasizes personalized and multidisciplinary integrated approaches to provide patients with treatment plans that balance efficacy and quality of life.

    • 马晓颖教授现场图1
    • 马晓颖教授现场图2
    • 马晓颖教授现场图3
    • Indonesian Breast Cancer Patient: ANY

      Diagnosed with breast cancer during pregnancy, underwent a left mastectomy. Postpartum hormonal fluctuations caused the tumor to rapidly expand from 3cm to 29cm within 3 months, accompanied by ulceration and infection risk. Under the leadership of Professor Song, the MDT team tailored a treatment plan including interventional therapy + R0 radical resection + postoperative vacuum sealing drainage (VSD) technology + subsequent breast reconstruction. They successfully removed the massive tumor weighing 3.5kg. The patient recovered well post-surgery and regained a new life.

      印尼乳腺癌 娅尼(ANY)

      more >

    • Russian Dual Primary Cancers (lung cancer+rectal cancer): Radik

      Radik, a 63-year-old Russian engineer, was diagnosed with the rare occurrence of synchronous primary malignancies: rectal adenocarcinoma and lung squamous cell carcinoma. After seeking consultations across multiple countries, he consistently received recommendations for "surgical resection with permanent stoma". Professor Song Shijun emphasized: "The distinct biological behavior, pathological types, and staging of these two separate tumors demand a dual-focused therapeutic approach." Following a MDT discussion, Radik underwent combined interventional therapy and immunotherapy. Radik's lung and intestinal tumors shrank significantly, and his symptoms of coughing and bloody stools disappeared.

      俄罗斯双原位肿瘤(肺癌+肠癌) 雷迪克(Radik)

      more >

  • Professor Song Shijun Dialogue with ASEAN Oncology Experts

    ASEAN International Minimally Invasive Oncology Expert
    Chief Oncology Expert, Modern Cancer Hospital Guangzhou

    “Tailoring life plans for patients is a doctor's lifelong duty.”

    Professor Song Shijun brings over 40 years of clinical oncology experience. He is a senior member of the Chinese Society of Clinical Oncology (CSCO), the American Society of Clinical Oncology (ASCO), and the European Society for Medical Oncology (ESMO), and has long been active on the frontlines of medical exchange between China and Southeast Asia. Specializes in chemotherapy, targeted therapy, and minimally invasive therapy for various solid tumors. Particularly experienced in lung cancer, breast cancer, esophageal cancer, and colorectal cancer, with extensive experience in diagnosing and treating clinically challenging malignant tumors. Has treated over ten thousand patients from China and abroad, significantly extending the survival of many patients with advanced-stage cancer.

    • 宋士军教授现场图1
    • 宋士军教授现场图2
    • 宋士军教授现场图3
    • Indonesian Breast Cancer Patient: ANY

      Diagnosed with breast cancer during pregnancy, underwent a left mastectomy. Postpartum hormonal fluctuations caused the tumor to rapidly expand from 3cm to 29cm within 3 months, accompanied by ulceration and infection risk. Under the leadership of Professor Song, the MDT team tailored a treatment plan including interventional therapy + R0 radical resection + postoperative vacuum sealing drainage (VSD) technology + subsequent breast reconstruction. They successfully removed the massive tumor weighing 3.5kg. The patient recovered well post-surgery and regained a new life.

      印尼乳腺癌 娅尼(ANY)

      more >

    • Russian Dual Primary Cancers (lung cancer+rectal cancer): Radik

      Radik, a 63-year-old Russian engineer, was diagnosed with the rare occurrence of synchronous primary malignancies: rectal adenocarcinoma and lung squamous cell carcinoma. After seeking consultations across multiple countries, he consistently received recommendations for "surgical resection with permanent stoma". Professor Song Shijun emphasized: "The distinct biological behavior, pathological types, and staging of these two separate tumors demand a dual-focused therapeutic approach." Following a MDT discussion, Radik underwent combined interventional therapy and immunotherapy. Radik's lung and intestinal tumors shrank significantly, and his symptoms of coughing and bloody stools disappeared.

      俄罗斯双原位肿瘤(肺癌+肠癌) 雷迪克(Radik)

      more >

  • 戴文燕教授 戴文燕教授

    Professor Dai Wenyan Dialogue with ASEAN Oncology Experts

    ASEAN International Minimally Invasive Oncology Expert
    Head of the Breast Cancer Department, Modern Cancer Hospital Guangzhou

    “Every promotion is not just an honor, but also a responsibility.”

    Professor Dai Wenyan has dedicated over two decades to the field of minimally invasive oncology and personalized treatment. She currently holds key positions in multiple national and international oncology professional committees, including serving as a standing committee member of the Individualized Therapy Expert Committee of the Chinese Anti-Cancer Association and a committee member of the Particle Therapy Committee of the Chinese Anti-Cancer Association.
    After furthering her studies at the National Cancer Centre Singapore, Professor Dai Wenyan introduced the concept of “patient-centered, whole-process management” into the development of the breast cancer department. She established and led a team to create a precision diagnosis and treatment system centered around minimally invasive techniques and supported by integrated therapies, offering more survival opportunities for patients with advanced-stage breast cancer.

    • 戴文燕教授现场图1
    • 戴文燕教授现场图2
    • 戴文燕教授现场图3
    • Indonesian Breast Cancer Patient:Ms. Lin

      Ms. Lin was unexpectedly diagnosed with breast cancer, which had already metastasized to her axillary lymph nodes and bones. The tumor was compressing her spinal cord, putting her at risk of paralysis. At our hospital, she underwent spinal surgery combined with systematic endocrine therapy. As a result, the tumors in her body achieved a Partial Response (PR) status, meaning the tumors had shrunk by more than 50%. Her muscle strength in both lower limbs fully recovered, and she successfully overcame the crisis of paralysis.

      印尼乳腺癌 林女士
    • Indonesian Kidney Cancer Patient: Mr. An

      After being diagnosed with clear cell renal cell carcinoma, Mr. An did not receive timely treatment, which led to metastases to his brain, lungs, and multiple bones. He was even bedridden due to paralysis. However, after undergoing our hospital’s individualized treatment plan of “targeted therapy combined with immunotherapy”, within a month, Mr. An’s pain was significantly alleviated. All metastatic lesions throughout his body were effectively controlled. His bilateral muscle strength recovered from grade 1 to grade 5, enabling him to stand and walk on his own.

      印尼肾癌 安先生
  • Professor Ma Xiaoying Dialogue with ASEAN Oncology Experts

    ASEAN International Minimally Invasive Oncology Expert
    Expert in Minimally Invasive Oncology, Modern Cancer Hospital Guangzhou

    “Medicine is not merely about curing diseases; it is an art related to the quality of life.”

    Professor Ma Xiaoying is an internationally renowned expert in minimally invasive oncology. She serves as a committee member of the Medical Oncology and Endoscopic Oncology Committees of the Chinese Anti-Cancer Association. With over two decades of clinical experience in oncology, she has treated more than 5,000 cross-border patients from Southeast Asia.
    She excels in chemotherapy, targeted therapy, and immunotherapy for solid tumors such as lung cancer, gastrointestinal, gynecological, and genitourinary cancers. In particular, she specializes in minimally invasive comprehensive treatment plans for advanced-stage and refractory tumors. Her team has completed over a thousand minimally invasive surgeries, significantly prolonging patients’ survival periods. They consistently adhere to the treatment philosophy of “improving therapeutic effects and alleviating pain.”

    • 马晓颖教授现场图1
    • 马晓颖教授现场图2
    • 马晓颖教授现场图3
    • Vietnamese Cholangiocarcinoma Patient: Đặng Thị Len

      Six years ago, upon diagnosis, her tumor compression led to jaundice, loss of appetite, drastic weight loss, and extreme physical weakness. Her condition was complex and challenging. The local hospital estimated her survival period to be only 3 - 6 months. However, after receiving a comprehensive treatment of seed implantation, interventional therapy, and photodynamic therapy at Modern Cancer Hospital Guangzhou , her tumor was effectively controlled. To date, there has been no recurrence, and she has been “clinically cured” for six years.

      越南胆管癌 邓氏毛

      more >

    • Vietnamese Liver Cancer Patient: VO VAN HOA

      Due to persistent fatigue, VO VAN HOA experienced recurrent low-grade fever, distending pain in the upper right abdomen, headaches, and facial nerve involvement, resulting in numbness and pain in the jaw and lips. In 2019, he was diagnosed with massive hepatocellular carcinoma. Unwilling to undergo traditional surgery locally, he sought treatment at Modern Cancer Hospital Guangzhou , where he underwent minimally invasive therapy combining interventional therapy and NanoKnife ablation. As a result, the original 70×60 mm tumor was completely necrotized with no residual active cancer cells. Six years later, he remains recurrence-free and has returned to a normal life.

      越南肝癌 武文华

      more >

×

ASEAN Experts In-Person Consultation Booking Zone

东盟大会活动图

To facilitate Southeast Asian patients in securing priority access to leading medical experts, the “Exclusive Booking Period” is now open— secure your chance to book an expert consultation in advance:

【Exclusive Booking Period】 June 22 - July 15

【Exclusive Booking Benefits】 ✔ The first 10 successful bookings will receive an exclusive gift. ✔ Opportunity to receive medical aid support after completing the consultation. *For full details, please contact our Malaysia International Service Center.

⚠ Limited availability—only the first batch of slots open! If you or your loved ones are seeking treatment options, fill out the form now to secure your expert consultation!

Patient's Name *
Cancer type *
Phone number/Whatsapp *
age
email
Medical reports*
Contact us *

Technology Paves the Way for Treatment: Combating Cancer Without Surgery

A Glimpse of Past ASEAN Forums

  • Winning in Cancer Treatment Through Integration: The 1st ASEAN International Integrated Oncology Medicine Session

    Winning in Cancer Treatment Through Integration: The 1st ASEAN International Integrated Oncology Medicine Session

    Since the launch of the first ASEAN International Oncology Integrative Medicine Session in 2020, it has been successfully held for three sessions, becoming a vital platform for cross - border exchanges of anti - cancer experiences, technologies, and concepts. We have witnessed:

    • ◆ Over 200 oncology experts and scholars from five ASEAN countries engaging in in-depth exchanges both online and offline.
    • ◆ The formation of a trinity cooperation mechanism of “remote assessment + academic dialogue + joint ward rounds”, creating a “borderless tumor assistance chain”.
    • ◆ Tens of thousands of patients with advanced-stage cancer establishing connections with ASEAN oncology experts through the forum platform and successfully receiving effective treatments.
    • Winning in Cancer Treatment Through Integration: The 1st ASEAN International Integrated Oncology Medicine Session
    • Putting Integrated Medicine into Practice, Joining Hands Across Borders to Fight Cancer: The 2nd ASEAN International Integrated Oncology Medicine Session
    • Winning in Cancer Treatment Through Integration: The 3rd ASEAN International Integrated Oncology Medicine Session
    • China Anti-Cancer Association Integrated Oncology Medicine Training Base settled in Guangdong

Since the launch of the first ASEAN International Oncology Integrative Medicine Session in 2020, it has been successfully held for three sessions, becoming a vital platform for cross - border exchanges of anti - cancer experiences, technologies, and concepts. We have witnessed:

  • ◆ Over 200 oncology experts and scholars from five ASEAN countries engaging in in-depth exchanges both online and offline.
  • ◆ The formation of a trinity cooperation mechanism of “remote assessment + academic dialogue + joint ward rounds”, creating a “borderless tumor assistance chain”.
  • ◆ Tens of thousands of patients with advanced-stage cancer establishing connections with ASEAN oncology experts through the forum platform and successfully receiving effective treatments.
  • Winning in Cancer Treatment Through Integration: The 1st ASEAN International Integrated Oncology Medicine Session

    Winning in Cancer Treatment Through Integration: The 1st ASEAN International Integrated Oncology Medicine Session

  • Putting Integrated Medicine into Practice, Joining Hands Across Borders to Fight Cancer: The 2nd ASEAN International Integrated Oncology Medicine Session

    Putting Integrated Medicine into Practice, Joining Hands Across Borders to Fight Cancer: The 2nd ASEAN International Integrated Oncology Medicine Session

  • Winning in Cancer Treatment Through Integration: The 3rd ASEAN International Integrated Oncology Medicine Session

    Winning in Cancer Treatment Through Integration: The 3rd ASEAN International Integrated Oncology Medicine Session

  • China Anti-Cancer Association Integrated Oncology Medicine Training Base settled in Guangdong

    China Anti-Cancer Association Integrated Oncology Medicine Training Base settled in Guangdong

Highlights of ASEAN International Integrated Oncology Medicine Session

  • 东盟国际整合肿瘤医学论坛集锦1
  • 东盟国际整合肿瘤医学论坛集锦2
  • 东盟国际整合肿瘤医学论坛集锦3
  • 东盟国际整合肿瘤医学论坛集锦4
  • 东盟国际整合肿瘤医学论坛集锦5
  • 东盟国际整合肿瘤医学论坛集锦6
  • 东盟国际整合肿瘤医学论坛集锦7
  • 东盟国际整合肿瘤医学论坛集锦8
Form
Patient's Name *
Cancer type *
Phone number/Whatsapp *
age
email
Medical reports*
Contact us *
Appointment Form Online Consultation [email protected] BACKTOP
Leave
a message